A novel biodegradable delivery system for bone morphogenetic protein-2

Plastic and Reconstructive Surgery

Volumn 121, Issue 6, 2008, Pages 1920-1928

  Engstrand, Thomas ^a   Veltheim, Riikka ^a   Arnander, Claes ^a   Docherty Skogh, Ann Charlott ^a   Westermark, Anders ^a   Ohlsson, Claes ^a   Adolfsson, Lars ^a   Larm, Olle ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CHITOSAN; COLLAGEN TYPE 1; HEPARIN; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; DRUG CARRIER; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; BONE DEVELOPMENT; BONE REMODELING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; FREEZE DRYING; GEL; HISTOLOGY; IN VITRO STUDY; LEG; MALE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RAT; ANIMAL; BIODEGRADABLE IMPLANT; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; IMPLANT; NEEDLE BIOPSY; PHYSIOLOGY; RANDOMIZATION; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT;

ABSORBABLE IMPLANTS; ANIMALS; BIOCOMPATIBLE MATERIALS; BIOPSY, NEEDLE; BONE MORPHOGENETIC PROTEINS; CHITOSAN; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HEPARIN; IMMUNOHISTOCHEMISTRY; IMPLANTS, EXPERIMENTAL; MALE; OSTEOGENESIS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA;

EID: 48049091844     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31817151b0     Document Type: Article

References (20)

1. Chen, R. R., and Mooney, D. J. Polymeric growth factor delivery strategies for tissue engineering. Pharm. Res. 20: 1103, 2003.
2. Tabata, Y. Tissue regeneration based on growth factor release. Tissue Eng. 9(Suppl. 1): S5, 2003.
3. Ramoshebi, L. N., Matsaba, T. N., Teare, J., et al. Tissue engineering: TGF-beta superfamily members and delivery systems in bone regeneration. Expert Rev. Mol. Med. 4: 1, 2002.
4. Damon, D. H., Lobb, R. R., D'Amore, P. A., and Wagner, J. A. Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half-life. J. Cell. Physiol. 138: 221, 1989.
5. Fisher, M. C., Li, Y., Seghatoleslami, M. R., Dealy, C. N., and Kosher, R. A. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation. Matrix Biol. 25: 27, 2006.
6. Filmus, J., and Selleck, S. B. Glypicans: Proteoglycans with a surprise. J. Clin. Invest. 108: 497, 2001.
7. Mulloy, B., and Linhardt, R. J. Order out of complexity: Protein structures that interact with heparin. Curr. Opin. Struct. Biol. 11: 623, 2001.
8. Casu, B., and Lindahl, U. Structure and biological interactions of heparin and heparan sulfate. Adv. Carbohydr. Chem. Biochem. 57: 159, 2001.
9. Besner, G., Higashiyama, S., and Klagsbrun, M. Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regul. 1: 811, 1990.
10. Klagsbrun, M. The affinity of fibroblast growth factors (FGFs) for heparin; FGF-heparan sulfate interactions in cells and extracellular matrix. Curr. Opin. Cell Biol. 2: 857, 1990.
11. Takada, T., Katagiri, T., Ifuku, M., et al. Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J. Biol. Chem. 278: 43229, 2003.
12. Zhao, B., Katagiri, T., Toyoda, H., et al. Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J. Biol. Chem. 281: 23246, 2006.
13. Arnander, C., Westermark, A., Veltheim, R., et al. Three-dimensional technology and bone morphogenetic protein in frontal bone reconstruction. J. Craniofac. Surg. 17: 275, 2006.
14. Kaiser, W., and Zollner, N. Half-life and clearance of heparin in man. Verh. Dtsch. Ges. Inn. Med. 77: 1025, 1971.
15. Pangburn, S. H., Trescony, P. V., and Heller, J. Lysozyme degradation of partially deacetylated chitin, its films and hydrogels. Biomaterials 3: 105, 1982.
16. Varum, K. M., Myhr, M. M., Hjerde, R. J., et al. In vitro degradation rates of partially N-acetylated chitosans in human serum. Carbohydr. Res. 299: 99, 1997.
17. Kratz, G., Arnander, C., Swedenborg, J., et al. Heparin-chitosan complexes stimulate wound healing in human skin. Scand. J. Plast. Reconstr. Surg. Hand Surg. 31: 119, 1997.
18. Kratz, G., Back, M., Arnander, C., et al. Immobilised heparin accelerates the healing of human wounds in vivo. Scand. J. Plast. Reconstr. Surg. Hand Surg. 32: 381, 1998.
19. Lopez-Lacomba, J. L., Garcia-Cantalejo, J. M., Sanz Casado, J. V., et al. Use of rhBMP-2 activated chitosan films to improve osseointegration. Biomacromolecules 7: 792, 2006.
20. Park, Y. J., Kim, K. H., Lee, J. Y., et al. Immobilization of bone morphogenetic protein-2 on a nanofibrous chitosan membrane for enhanced guided bone regeneration. Biotechnol. Appl. Biochem. 43: 17, 2006.